Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01774097 · ClinicalTrials.gov registry record · Phase 2
Patients With Intermittent Claudication Injected With ALDH Bright Cells
A Phase 2 study, sponsored by The University of Texas Health Science Center, Houston.
- Completed
- Registry status
- Phase 2
- Development phase
- 82
- Enrollment target
NCT01774097 is a Phase 2 study that has completed, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 82 participants.
The verdict
NCT01774097, a Phase 2 study, has completed, sponsored by The University of Texas Health Science Center, Houston.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 82 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pain associated with blocked blood vessels in the leg.
Interventions
- BIOLOGICAL ALD-301
- BIOLOGICAL Placebo (vehicle)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 82 participants |
| Start Date | 2013-06 |
| Est. Completion | 2017-03 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01774097
The ClinicalTrials.gov registry entry for NCT01774097 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 82 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ALD-301 is the first listed.
NCT01774097 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01774097 about?
NCT01774097 is a clinical study titled "Patients With Intermittent Claudication Injected With ALDH Bright Cells". The purpose of this study is to find out if aldehyde dehydrogenase bright (ALDHbr) cells taken from a patient's bone marrow can be placed safely, via intramuscular injections, into their affected calf and lower thigh muscles and improve blood flow and/or peak walking time in patients experiencing pa...
What is the current status of trial NCT01774097?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 82 participants. The study started on 2013-06. Estimated completion is 2017-03.
What interventions are being tested in trial NCT01774097?
The interventions under investigation include: ALD-301 (BIOLOGICAL), Placebo (vehicle) (BIOLOGICAL).
Who is sponsoring clinical trial NCT01774097?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.